tiprankstipranks
Trending News
More News >
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Japanese Market

Cosmo Bio Co., Ltd. (3386) Financial Statements

Compare
0 Followers

Cosmo Bio Co., Ltd. Financial Overview

Cosmo Bio Co., Ltd.'s market cap is currently ¥7.94B. The company's EPS TTM is ¥11.3; its P/E ratio is 23.54; and it has a dividend yield of 4.57%. Cosmo Bio Co., Ltd. is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 10.77B¥ 10.04B¥ 9.34B¥ 9.55B¥ 9.23B
Gross Profit¥ 3.70B¥ 3.33B¥ 3.25B¥ 3.44B¥ 3.66B
Operating Income¥ 342.00M¥ 318.00M¥ 519.00M¥ 816.00M¥ 1.05B
EBITDA¥ 509.00M¥ 455.00M¥ 801.00M¥ 931.00M¥ 1.26B
Net Income¥ 336.00M¥ 262.00M¥ 442.00M¥ 517.00M¥ 737.00M
Balance Sheet
Cash & Short-Term Investments¥ 2.95B¥ 2.69B¥ 3.02B¥ 3.04B¥ 3.56B
Total Assets¥ 12.66B¥ 11.72B¥ 10.87B¥ 10.31B¥ 10.07B
Total Debt¥ 20.00M¥ 20.00M¥ 20.00M¥ 20.00M¥ 20.00M
Net Debt¥ -2.73B¥ -2.37B¥ -2.81B¥ -3.02B¥ -3.23B
Total Liabilities¥ 2.70B¥ 2.17B¥ 1.85B¥ 1.70B¥ 1.75B
Stockholders' Equity¥ 9.37B¥ 8.97B¥ 8.45B¥ 8.05B¥ 7.79B
Cash Flow
Free Cash Flow¥ 366.00M¥ 25.00M¥ 636.00M¥ 180.00M¥ 507.00M
Operating Cash Flow¥ 595.00M¥ 241.00M¥ 736.00M¥ 284.00M¥ 648.00M
Investing Cash Flow¥ 43.00M¥ -217.00M¥ -758.00M¥ -291.00M¥ -145.00M
Financing Cash Flow¥ -283.00M¥ -479.00M¥ -201.00M¥ -236.00M¥ -420.00M
Currency in JPY

Cosmo Bio Co., Ltd. Earnings and Revenue History

Cosmo Bio Co., Ltd. Debt to Assets

Cosmo Bio Co., Ltd. Cash Flow

Cosmo Bio Co., Ltd. Forecast EPS vs Actual EPS